In this issue, Fribourg et al. provide insight into a molecular basis of psychosis. They reveal that a heteromeric complex formed by the G protein-coupled receptors (GPCRs) for glutamate and serotonin is a convergent site for the activity of anti-or propsychotic drugs, opening a possibility for new therapeutic strategies for schizophrenia.
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)